Granules India Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

593.60

-12.40 (-2.05%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

593.60

-12.40 (-2.05%)
15:57 Jan 10

Quality

66/100
High Financial Strength

Valuation

41/100
Mid Valuation

Technical

57/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	3237.54	3764.92	4511.92	4506.37	4477.84
Operating Expenses +	2382.32	3042.69	3598.1	3650.39	3509.08
Raw Material	1590.28	2036.42	2352.65	2208.22	1945.25
Increase Decrease in Cost	-199	-152.78	-45.37	-186.97	-126.65
Other Manufacturing Expense	17.26	22.01	19.98	0	0
Employee Cost	408.18	401.38	472.23	597.86	631.74
Miscellaneous Expenses	565.6	735.66	798.61	1031.28	1058.74
Operating Profit	855.22	722.23	913.82	855.98	968.76
Other Income	26.88	17.61	13.78	4.4	7.84
Depreciation	151.46	158.63	184.49	207.33	210.96
Interest	26.28	23.21	55.93	105.82	110.1
Profit before tax and exceptio..	704.36	558	687.17	547.23	655.54
Exceptional Items	0	0	0	0	0
PBT	704.36	558	687.17	547.23	655.54
Provision for Taxation	154.91	145.24	170.58	141.92	168.38
Net Profit	549.46	412.76	516.6	405.31	487.18
NET Profit after MI	549.46	412.76	516.6	405.31	487.18
EPS	21.95	16.6	21	16.73	20.1
Operating Profit Margin (%)	26.42	19.18	20.25	18.99	21.63
Net Profit Margin (%)	16.97	10.96	11.45	8.99	10.88

ShareHolding

All Data in Percentage (%)

	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23
Promoter	38.80	38.90	38.90	42.00	42.00
FII	15.90	19.50	20.40	19.60	18.80
MF	10.40	7.90	9.20	7.10	7.00
Public	25.70	26.80	26.60	27.80	29.10
Others	0.10	0.00	0.00	0.00	0.00
Others	9.10	6.90	4.90	3.50	3.10